Lunai Bioworks Inc. (LNAI)

Lunai Bioworks Inc. (LNAI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.3M; returns 1 day -37.3%, 1 week -56.7%, 1 year -96.5%.

Lunai Bioworks Inc. (formerly Renovaro Inc.) is an AI-driven biotechnology company specializing in allogeneic cell and gene therapies and multi-omics diagnostics. The company operates through three primary segments: RENB (immunotherapy), BioSymetrics (AI drug discovery), and RENC (diagnostics).

Groups LNAI belongs to

• Artificial Intelligence
• Recent Reverse Splits
• Biotechnology
• Biopharmaceutical
• AI in Healthcare
• Drug Discovery
• Immunotherapy
• Gene Therapy
• Oncology
• Life Sciences
• Healthcare Technology
• Machine Learning

LNAI financial model: income statement, cash flow and balance sheet